These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release. Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414 [TBL] [Abstract][Full Text] [Related]
3. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation. Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792 [TBL] [Abstract][Full Text] [Related]
4. [The synergistic effects of lipopolysaccharide, bacterial lipoprotein and bacterial DNA on mouse alveolar macrophage activation]. Huang H; Jiang JX; Zhu PF; Wang ZG; Zhang DJ; Yang C Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1468-72. PubMed ID: 16061024 [TBL] [Abstract][Full Text] [Related]
5. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling. Lim EJ; Lee SH; Lee JG; Chin BR; Bae YS; Kim JR; Lee CH; Baek SH FEBS Lett; 2006 Aug; 580(18):4533-8. PubMed ID: 16870179 [TBL] [Abstract][Full Text] [Related]
6. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells. He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112 [TBL] [Abstract][Full Text] [Related]
8. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis. Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640 [TBL] [Abstract][Full Text] [Related]
9. MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands. Zheng H; Heiderscheidt CA; Joo M; Gao X; Knezevic N; Mehta D; Sadikot RT Eur J Immunol; 2010 Jan; 40(1):162-71. PubMed ID: 19904768 [TBL] [Abstract][Full Text] [Related]
10. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity. Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053 [TBL] [Abstract][Full Text] [Related]
11. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. Merlo A; Calcaterra C; Mènard S; Balsari A J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660 [TBL] [Abstract][Full Text] [Related]
12. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge. Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479 [TBL] [Abstract][Full Text] [Related]
13. Azithromycin acts as an immunomodulatory agent to suppress the expression of TREM-1 in Bacillus pyocyaneus-induced sepsis. Tong J; Liu ZC; Wang DX Immunol Lett; 2011 Aug; 138(2):137-43. PubMed ID: 21507332 [TBL] [Abstract][Full Text] [Related]
14. CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9. Shimosato T; Fujimoto M; Tohno M; Sato T; Tateo M; Otani H; Kitazawa H Biochem Biophys Res Commun; 2010 Mar; 394(1):81-6. PubMed ID: 20178773 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression. Lim EJ; Lee SH; Lee JG; Kim JR; Yun SS; Baek SH; Lee C Exp Mol Med; 2007 Apr; 39(2):239-45. PubMed ID: 17464186 [TBL] [Abstract][Full Text] [Related]
16. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Tabeta K; Georgel P; Janssen E; Du X; Hoebe K; Crozat K; Mudd S; Shamel L; Sovath S; Goode J; Alexopoulou L; Flavell RA; Beutler B Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3516-21. PubMed ID: 14993594 [TBL] [Abstract][Full Text] [Related]
18. Cutting edge: TREM-2 attenuates macrophage activation. Turnbull IR; Gilfillan S; Cella M; Aoshi T; Miller M; Piccio L; Hernandez M; Colonna M J Immunol; 2006 Sep; 177(6):3520-4. PubMed ID: 16951310 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the lipopolysaccharide-induced transcription of the human TREM-1 gene in vitamin D3-matured THP-1 macrophage-like cells. Hosoda H; Tamura H; Nagaoka I Int J Mol Med; 2015 Nov; 36(5):1300-10. PubMed ID: 26397033 [TBL] [Abstract][Full Text] [Related]
20. Silencing of triggering receptor expressed on myeloid cells-2 enhances the inflammatory responses of alveolar macrophages to lipopolysaccharide. Gao X; Dong Y; Liu Z; Niu B Mol Med Rep; 2013 Mar; 7(3):921-6. PubMed ID: 23314916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]